泰福生技股份有限公司
泰福生技股份有限公司（Tanvex BioPharma, Inc.）研發、製造並銷售生物相似藥（Biosimilars）。專注於治療嗜中性白血球減少症、乳癌及大腸癌之生物藥。研發管線包含 TX01、TX05（已進入臨床三期）及其他產品。公司成立於 2013 年，總部位於台灣台北（註冊於開曼群島）。
今日上漲 1.97%，股價站回短期均線。該股 RSI(6) 為 58.9，處於中性區間，短線無明顯超買超賣訊號。股價站上5日、20日均線，跌破60日、120日均線。短中期均線呈空頭排列，趨勢偏空。KD 指標中性（K=51.5）；MACD 柱狀體為正值，維持多方動能。 （自動產生 · 非投資建議）
| 日期 | 外資 | 投信 | 自營商 | 合計 |
|---|---|---|---|---|
| 08-10 | +57 | 0 | -3 | +54 |
| 08-07 | +98 | 0 | 0 | +98 |
| 08-06 | +112 | 0 | 0 | +112 |
| 08-05 | +168 | 0 | 0 | +168 |
| 08-04 | -110 | 0 | -9 | -119 |
| 08-03 | +49 | 0 | -7 | +42 |
| 07-31 | -2 | 0 | +1 | -1 |
| 07-30 | -68 | 0 | -3 | -71 |
| 07-29 | +36 | 0 | +7 | +42 |
| 07-28 | 0 | 0 | 0 | 0 |
| 07-27 | +48 | 0 | 0 | +48 |
| 07-24 | -87 | 0 | +1 | -86 |
| 07-23 | -213 | 0 | +2 | -211 |
| 07-22 | +2 | 0 | -6 | -4 |
| 07-21 | +124 | 0 | 0 | +124 |
| 07-20 | +60 | 0 | +2 | +63 |
| 07-17 | -92 | 0 | +3 | -89 |
| 07-16 | +62 | 0 | +2 | +64 |
| 07-15 | +137 | 0 | -6 | +131 |
| 07-14 | +18 | 0 | +5 | +23 |
| 07-13 | -10 | 0 | +5 | -5 |
| 07-09 | +35 | 0 | -3 | +32 |
| 07-08 | -69 | 0 | +1 | -68 |
| 07-07 | +81 | 0 | 0 | +81 |
| 07-06 | +86 | 0 | +1 | +87 |
| 07-03 | +225 | 0 | +1 | +226 |
| 07-02 | -96 | 0 | -1 | -97 |
| 07-01 | +179 | 0 | 0 | +179 |
| 06-30 | -32 | 0 | +1 | -31 |
| 06-29 | -55 | 0 | 0 | -55 |
| 06-26 | -159 | 0 | 0 | -159 |
| 06-25 | -712 | 0 | 0 | -712 |
| 06-24 | +114 | 0 | +3 | +117 |
| 06-22 | +184 | 0 | 0 | +184 |
| 06-18 | +1 | 0 | -3 | -2 |
| 06-17 | -12 | 0 | +5 | -7 |
| 06-16 | +103 | 0 | -1 | +102 |
| 06-15 | +2 | 0 | 0 | +2 |
| 06-12 | +68 | 0 | +1 | +69 |
| 06-10 | -149 | 0 | -3 | -152 |
| 06-09 | -76 | 0 | -1 | -77 |
| 06-08 | -34 | 0 | +1 | -34 |
| 06-04 | +17 | 0 | +1 | +18 |
| 06-03 | -63 | 0 | -5 | -68 |
| 06-02 | -129 | 0 | +3 | -126 |
| 06-01 | +174 | 0 | 0 | +174 |
| 05-29 | +261 | 0 | +1 | +262 |
| 月份 | 營收 | MoM% | YoY% |
|---|---|---|---|
| 2026/06 | 9757 萬 | +170.4% | +267.4% |
| 2026/05 | 3608 萬 | -58.4% | +208.2% |
| 2026/04 | 8679 萬 | -6.1% | +914.9% |
| 2026/03 | 9246 萬 | +306.9% | +134.7% |
| 2026/02 | 2272 萬 | +28.7% | +218.7% |
| 2026/01 | 1765 萬 | -12.3% | +428.9% |
| 2025/12 | 2013 萬 | -82.0% | +3933.7% |
| 2025/11 | 1.12 億 | +139.1% | +8351.6% |
| 2025/10 | 4684 萬 | -44.8% | +4650.6% |
| 2025/09 | 8486 萬 | +259.6% | +3916.1% |
| 2025/08 | 2360 萬 | +39.8% | +1611.1% |
| 2025/07 | 1688 萬 | - | +110.7% |